|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online March 23, 2006
doi: 10.1242/10.1242/dev.02333

1 Department of Genetics, Cell Biology, and Development, University of
Minnesota, Minneapolis, MN 55455, USA.
2 The Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN
55455, USA.
3 Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455,
USA.
Authors for correspondence (e-mail:
moconnor{at}mail.med.umn.edu
and
ecoucouvanis{at}gmail.com)
Accepted 9 February 2006
TGFß activated kinase 1 (TAK1) is a MAPKKK that in cell culture systems has been shown to act downstream of a variety of signaling molecules, including TGFß. Its role during vertebrate development, however, has not been examined by true loss-of-function studies. In this report, we describe the phenotype of mouse embryos in which the Tak1 gene has been inactivated by a genetrap insertion. Tak1 mutant embryos exhibit defects in the developing vasculature of the embryo proper and yolk sac. These defects include dilation and misbranching of vessels, as well as an absence of vascular smooth muscle. The phenotype of Tak1 mutant embryos is strikingly similar to that exhibited by loss-of-function mutations in the TGFß type I receptor Alk1 and the type III receptor endoglin, suggesting that TAK1 may be a major effector of TGFß signals during vascular development. Consistent with this view, we find that in zebrafish, morpholinos to TAK1 and ALK1 synergize to enhance the Alk1 vascular phenotype. Moreover, we show that overexpression of TAK1 is able to rescue the vascular defect produced by morpholino knockdown of ALK1. Taken together, these results suggest that TAK1 is probably an important downstream component of the TGFß signal transduction pathway that regulates vertebrate vascular development. In addition, as heterozygosity for mutations in endoglin and ALK1 lead to the human syndromes known as hereditary hemorrhagic telangiectasia 1 and 2, respectively, our results raise the possibility that mutations in human TAK1 might contribute to this disease.
Key words: TAK1 (MAP3K7), Angiogenesis, ALK1 (ACVRL1), HHT, TGFß
This article has been cited by other articles:
![]() |
W. J. French, E. E. Creemers, and M. D. Tallquist Platelet-Derived Growth Factor Receptors Direct Vascular Development Independent of Vascular Smooth Muscle Cell Function Mol. Cell. Biol., September 15, 2008; 28(18): 5646 - 5657. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kajino-Sakamoto, M. Inagaki, E. Lippert, S. Akira, S. Robine, K. Matsumoto, C. Jobin, and J. Ninomiya-Tsuji Enterocyte-Derived TAK1 Signaling Prevents Epithelium Apoptosis and the Development of Ileitis and Colitis J. Immunol., July 15, 2008; 181(2): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tang, X. Wei, Y. Guo, P. Breslin, S. Zhang, S. Zhang, W. Wei, Z. Xia, M. Diaz, S. Akira, et al. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice J. Exp. Med., July 7, 2008; 205(7): 1611 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Londesborough, K. Vaahtomeri, M. Tiainen, P. Katajisto, N. Ekman, T. Vallenius, and T. P. Makela LKB1 in endothelial cells is required for angiogenesis and TGF{beta}-mediated vascular smooth muscle cell recruitment Development, July 1, 2008; 135(13): 2331 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Buchner, F. Su, J. S. Yamaoka, M. Kamei, J. A. Shavit, L. K. Barthel, B. McGee, J. D. Amigo, S. Kim, A. W. Hanosh, et al. From the Cover: pak2a mutations cause cerebral hemorrhage in redhead zebrafish PNAS, August 28, 2007; 104(35): 13996 - 14001. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kajino, E. Omori, S. Ishii, K. Matsumoto, and J. Ninomiya-Tsuji TAK1 MAPK Kinase Kinase Mediates Transforming Growth Factor-beta Signaling by Targeting SnoN Oncoprotein for Degradation J. Biol. Chem., March 30, 2007; 282(13): 9475 - 9481. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Chase, F. Ulloa-Montoya, B. L. Kidder, and C. M. Verfaillie Islet-Derived Fibroblast-Like Cells Are Not Derived via Epithelial-Mesenchymal Transition From Pdx-1 or Insulin-Positive Cells Diabetes, January 1, 2007; 56(1): 3 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xie, D. Zhang, J. R. B. Dyck, Y. Li, H. Zhang, M. Morishima, D. L. Mann, G. E. Taffet, A. Baldini, D. S. Khoury, et al. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway PNAS, November 14, 2006; 103(46): 17378 - 17383. [Abstract] [Full Text] [PDF] |
||||